Skip to main content

Nasdaq News

Orum Doses First Patient In Phase 1 ORM-1153 Trial For Blood Cancer

2 days 22 hours ago
(RTTNews) - On Wednesday, Orum Therapeutics, Inc. (475830.KQ), a biotechnology company developing degrader-antibody conjugates (DACs), announced that the first patient has been dosed in a Phase 1 trial evaluating ORM-1153 in patients with relapsed or refractory acute myeloid leuk
RTTNews

Stocks Finish Lower Ahead of Wednesday’s CPI Report

2 days 23 hours ago
The S&P 500 Index ($SPX ) (SPY ) closed down by -0.02% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.31%. December E-mini S&P futures (ESZ26 ) fell -0.02%, and December E-mini...
Barchart
Checked
4 minutes 22 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed